SCHEMBL12849999

SCHEMBL12849999

N#CC1(COc2cncc(-c3cc(N)ncc3Cl)n2)CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 18/20 0.42
CCNT1 O60563 13/20 0.42
CCNK O75909 4/20 0.42
CDK2 P24941 4/20 0.42
CDK14 O94921 2/20 0.42
CDK1 P06493 2/20 0.42
CCNA2 P20248 2/20 0.42
CDK5 Q00535 2/20 0.42
CDK16 Q00536 2/20 0.42
CDK17 Q00537 1/20 0.42
CDK18 Q07002 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
CCNB1 P14635 1/20 0.37
CDK7 P50613 1/20 0.37
CCNH P51946 1/20 0.37
MNAT1 P51948 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CCNY Q8ND76 1/20 0.37
HDAC3 O15379 5/20 0.36
HDAC1 Q13547 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12466007 0.88 CDK9 (0.42) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL12850003 0.88 CDK9 (0.34) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL6119613 0.82 CCNT1 (0.56) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL6119600 0.82 CCNT1 (0.56) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL12850281 0.82 CCNT1 (0.55) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL12465753 0.78 CDK9 (0.34) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL15378038 0.78 CCNT1 (0.55) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL15378039 0.78 CCNT1 (0.55) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL12466075 0.78 CDK9 (0.34) CDK9CCNT1CCNKCDK2CDK14
SCHEMBL12465817 0.77 CDK9 (0.68) CDK9CCNT1CCNKCDK2CDK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed